Immunization Program
Immunization News
November 02, 2021
The Louisiana Department of Health is currently reviewing the guidance and underlying information, and will provide formal guidance to vaccine providers for children in Louisiana tomorrow.
November 02, 2021
Community flu and COVID clinics are open to the public, and walk-ups are welcome. Wear short or loose-fitting sleeves and, if you have it, bring your private insurance, Medicaid or Medicare card.
November 02, 2021
Community flu and COVID clinics are open to the public, and walk-ups are welcome. Wear short or loose-fitting sleeves and, if you have it, bring your private insurance, Medicaid or Medicare card.
November 02, 2021
Community flu and COVID clinics are open to the public, and walk-ups are welcome. Wear short or loose-fitting sleeves and, if you have it, bring your private insurance, Medicaid or Medicare card.
November 01, 2021
Effective today, Louisiana's Shot For $100 vaccine incentive program is back - and will extend to November 30 for the general public including college students eligible for the COVID vaccine in Louisiana. Families of 5-to-11-year-olds are now eligible.
October 22, 2021
In addition, a COVID-19 booster is recommended for everyone 18 years old and above who received the Janssen (Johnson & Johnson COVID-19) vaccine. This new guidance is effective immediately.
October 21, 2021
Each site is open 7 days a week from 8 a.m. to 6 p.m. with an ability to serve more than 150 patients daily per site.
October 05, 2021
The Louisiana Department of Health can confirm a COVID-19 outbreak connected to a recent wedding in Abbeville. The Department considers all attendees of this wedding to be exposed to COVID-19 and encourages all attendees to take public health precautions.
September 24, 2021
The Louisiana Department of Health is now operating 13 community-based monoclonal antibody therapy (mAb) treatment sites, including one in Baton Rouge, and is on track to open one additional site on Saturday.
September 13, 2021
Monoclonal antibodies are man-made antibodies produced in a laboratory that can mimic the human immune system response to infection. mAbs are designed to block viral attachment and entry into human cells, thus neutralizing the virus that causes COVID-19.